Patents by Inventor Tomomi Yoshida

Tomomi Yoshida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11859205
    Abstract: Culture media, which contain albumin carrying a reduced amount of fatty acid, are useful for culturing stem cells.
    Type: Grant
    Filed: June 11, 2020
    Date of Patent: January 2, 2024
    Assignee: AJINOMOTO CO., INC.
    Inventors: Yoko Kuriyama, Sho Senda, Yumi Ando, Tomomi Yoshida, Haruna Sato, Daisuke Ejima, Takayoshi Fujii, Masayo Date, Manabu Kitazawa
  • Publication number: 20230130549
    Abstract: An object of the present invention is to provide a production method for a synovium-derived mesenchymal stem cell, by which proliferation efficiency is improved so that a sufficient amount of synovium-derived mesenchymal stem cells can be obtained from a synovial tissue, a production method for a cell preparation for joint medical treatment using the production method for a synovium-derived mesenchymal stem cell, synovium-derived mesenchymal stem cell, and a cell preparation for a joint medical treatment. According to the present invention, there is provided a production method for a synovium-derived mesenchymal stem cell, which is a method of producing a synovium-derived mesenchymal stem cell from a synovial tissue, where the production method includes treating the synovial tissue with a mixed enzyme including one or more kinds of collagenases and one or more kinds of neutral proteases for 2 hours or more without causing the synovial tissue to undergo a disinfection step.
    Type: Application
    Filed: December 23, 2022
    Publication date: April 27, 2023
    Applicants: FUJIFILM Corporation, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
    Inventors: Ichiro SEKIYA, Mitsuru MIZUNO, Hisako KATANO, Nobutake OZEKI, Kentaro NAKAMURA, Tomomi YOSHIDA
  • Publication number: 20230132346
    Abstract: An object of the present invention is to provide a production method for a synovium-derived mesenchymal stem cell, which makes it possible to obtain a sufficient amount of synovium-derived mesenchymal stem cells from the synovial tissue, a production method for a cell preparation for joint medical treatment using the production method for a synovium-derived mesenchymal stem cell, synovium-derived mesenchymal stem cell, and a cell preparation for a joint medical treatment. According to the present invention, there is provided a production method for a synovium-derived mesenchymal stem cell, which includes treating a synovial tissue with an enzyme for 2 hours or more; and washing a mixture after the enzyme treatment until a residual enzyme concentration in a supernatant is 0.5 ng/mL or less, to obtain a synovium-derived mesenchymal stem cell.
    Type: Application
    Filed: December 23, 2022
    Publication date: April 27, 2023
    Applicants: FUJIFILM Corporation, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
    Inventors: Ichiro SEKIYA, Mitsuru MIZUNO, Hisako KATANO, Nobutake OZEKI, Kentaro NAKAMURA, Tomomi YOSHIDA
  • Publication number: 20200370006
    Abstract: Culture media, which contain albumin carrying a reduced amount of fatty acid, are useful for culturing stem cells.
    Type: Application
    Filed: June 11, 2020
    Publication date: November 26, 2020
    Applicant: AJINOMOTO CO., INC.
    Inventors: Yoko KURIYAMA, Sho SENDA, Yumi ANDO, Tomomi YOSHIDA, Haruna SATO, Daisuke EJIMA, Takayoshi FUJII, Masayo DATE, Manabu KITAZAWA
  • Patent number: 10745669
    Abstract: Cultivating a pluripotent stem cell in a medium comprising at least one member selected from the group consisting of ethanolamine, an ethanolamine analog, and a pharmaceutically acceptable salt thereof, and which is substantially free of ?-mercaptoethanol or contains ?-mercaptoethanol at a concentration of not more than 9 ?M, and the like, is effective for the proliferation of a pluripotent stem cell while maintaining an undifferentiated state.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: August 18, 2020
    Assignee: AJINOMOTO CO., LTD.
    Inventors: Sho Senda, Tomomi Yoshida, Satoru Okamoto, Yoko Kuriyama, Manabu Kitazawa, Ikue Harata, Nao Sugimoto
  • Patent number: 10662411
    Abstract: Cultivating a pluripotent stem cell in a medium comprising at least one member selected from the group consisting of ethanolamine, an ethanolamine analog, and a pharmaceutically acceptable salt thereof, and which is substantially free of ?-mercaptoethanol or contains ?-mercaptoethanol at a concentration of not more than 9 ?M, and the like, is effective for the proliferation of a pluripotent stem cell while maintaining an undifferentiated state.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: May 26, 2020
    Assignee: AJINOMOTO CO., INC.
    Inventors: Sho Senda, Tomomi Yoshida, Satoru Okamoto, Yoko Kuriyama, Manabu Kitazawa, Ikue Harata, Nao Sugimoto
  • Publication number: 20190136202
    Abstract: Cultivating a pluripotent stem cell in a medium comprising at least one member selected from the group consisting of ethanolamine, an ethanolamine analog, and a s pharmaceutically acceptable salt thereof, and which is substantially free of ?-mercaptoethanol or contains ?-mercaptoethanol at a concentration of not more than 9 ?M, and the like, is effective for the proliferation of a pluripotent stem cell while maintaining an undifferentiated state.
    Type: Application
    Filed: January 8, 2019
    Publication date: May 9, 2019
    Applicant: AJINOMOTO CO., INC.,
    Inventors: Sho SENDA, Tomomi YOSHIDA, Satoru OKAMOTO, Yoko KURIYAMA, Manabu KITAZAWA, Ikue HARATA, Nao SUGIMOTO
  • Publication number: 20160137633
    Abstract: Provided is a compound represented by the following general formula (I), or a pharmaceutically acceptable salt thereof. This novel compound has a glycogen-synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. In the formula, Ar is an aromatic carbocyclic ring or a heterocyclic ring; and Ar2 is represented by any one of the following rings and the like.
    Type: Application
    Filed: January 29, 2016
    Publication date: May 19, 2016
    Applicant: Ajinomoto Co., Inc.
    Inventors: Tadakiyo NAKAGAWA, Kayo Matsumoto, Sen Takeshita, Tomomi Yoshida, Munetaka Tokumasu, Hiroki Inoue, Kaori Kobayashi
  • Patent number: 9290487
    Abstract: Provided is a compound represented by the following general formula (I), or a pharmaceutically acceptable salt thereof. This novel compound has a glycogen-synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. In the formula, Ar is an aromatic carbocyclic ring or a heterocyclic ring; and Ar2 is represented by any one of the following rings and the like.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: March 22, 2016
    Assignee: AJINOMOTO CO., INC.
    Inventors: Tadakiyo Nakagawa, Kayo Matsumoto, Sen Takeshita, Tomomi Yoshida, Munetaka Tokumasu, Hiroki Inoue, Kaori Kobayashi
  • Publication number: 20160075993
    Abstract: Culture media, which contain albumin carrying a reduced amount of fatty acid, are useful for culturing stem cells.
    Type: Application
    Filed: November 27, 2015
    Publication date: March 17, 2016
    Applicant: AJINOMOTO CO., INC.
    Inventors: Yoko KURIYAMA, Shou SENDA, Yumi ANDO, Tomomi YOSHIDA, Haruna SATO, Daisuke EJIMA, Takayoshi FUJII, Masayo DATE, Manabu KITAZAWA
  • Publication number: 20150329832
    Abstract: Cultivating a pluripotent stem cell in a medium comprising at least one member selected from the group consisting of ethanolamine, an ethanolamine analog, and a pharmaceutically acceptable salt thereof, and which is substantially free of ?-mercaptoethanol or contains ?-mercaptoethanol at a concentration of not more than 9 ?M, and the like, is effective for the proliferation of a pluripotent stem cell while maintaining an undifferentiated state.
    Type: Application
    Filed: July 30, 2015
    Publication date: November 19, 2015
    Applicant: AJINOMOTO CO., INC.,
    Inventors: Sho SENDA, Tomomi YOSHIDA, Satoru OKAMOTO, Yoko KURIYAMA, Manabu KITAZAWA, lkue HARADA, Nao SUGIMOTO
  • Publication number: 20140336376
    Abstract: Provided is a compound represented by the following general formula (I), or a pharmaceutically acceptable salt thereof. This novel compound has a glycogen-synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. In the formula, Ar is an aromatic carbocyclic ring or a heterocyclic ring; and Ar2 is represented by any one of the following rings and the like.
    Type: Application
    Filed: May 2, 2014
    Publication date: November 13, 2014
    Applicant: Ajinomoto Co., Inc.
    Inventors: Tadakiyo NAKAGAWA, Kayo Matsumoto, Sen Takeshita, Tomomi Yoshida, Munetaka Tokumasu, Hiroki Inoue, Kaori Kobayashi
  • Patent number: D438791
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: March 13, 2001
    Assignee: Canon Kabushiki Kaisha
    Inventors: Hideaki Tsuruishi, Keita Yoshida, Tomomi Yoshida
  • Patent number: D439157
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: March 20, 2001
    Assignee: Canon Kabushiki Kaisha
    Inventors: Hideaki Tsuruishi, Keita Yoshida, Tomomi Yoshida
  • Patent number: D441285
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: May 1, 2001
    Assignee: Canon Kabushiki Kaisha
    Inventors: Hideaki Tsuruishi, Keita Yoshida, Tomomi Yoshida
  • Patent number: D441643
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: May 8, 2001
    Assignee: Canon Kabushiki Kaisha
    Inventors: Hideaki Tsuruishi, Keita Yoshida, Tomomi Yoshida
  • Patent number: D447937
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: September 18, 2001
    Assignee: Canon Kabushiki Kaisha
    Inventors: Hideaki Tsuruishi, Keita Yoshida, Tomomi Yoshida
  • Patent number: D447938
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: September 18, 2001
    Assignee: Canon Kabushiki Kaisha
    Inventors: Hideaki Tsuruishi, Keita Yoshida, Tomomi Yoshida
  • Patent number: D447945
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: September 18, 2001
    Assignee: Canon Kabushiki Kaisha
    Inventors: Hideaki Tsuruishi, Keita Yoshida, Tomomi Yoshida
  • Patent number: D447946
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: September 18, 2001
    Assignee: Caon Kabushiki Kaisha
    Inventors: Hideaki Tsuruishi, Keita Yoshida, Tomomi Yoshida